Paychex (NASDAQ: PAYX) is one of those stocks that you wish you bought last year every year. It’s not an explosive growth tech or pharma story- everyone knows the downsides of those. Rather, its a stock that steadily rises, year after year, with rising earnings and dividends, and management who seemingly know what they are doing to make this happen. In other words, real value creation. It....More>>>
Shares of UniCredit (BIT:UCG) have received a consensus recommendation of “Buy” from the five brokerages that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company.
Several research firms have weighed in on UCG. JPMorgan Chase restated a “buy”....More>>>
Factoring in a relatively modest outlook for Trump economic programme on Discover Financial Services (NYSE:DFS) makes the stock stand out attractive while its conservative risk programme and strong capital returns mean there is downside protection. Investors should buy.
When I last wrote about DFS I thought it looked attractive on the basis of its strong capital return credentials but argued....More>>>
(Photographer: Michael Nagle/Bloomberg)
Disclosure: I have no positions in Chevron, IBM, Coca Cola, Merck, Procter & Gamble, Verizon, Pfizer, ExxonMobil or any other stock mentioned in this article.
The Dow Jones Industrial Average ended 2017 up 25.1% for the year, lagging its all-time intraday high of 24,876.07 set on Dec. 18. The eight Dogs of the Dow for 2017 had an aggregate....More>>>
Edelweiss has come out with its fourth quarter (Jan-March 18) earnings estimates for the Pharma sector. The brokerage house expects Dr Reddy’s to report net profit at Rs. 268.4 crore up 16.7% year-on-year (down 20.2% quarter-on-quarter).
Net Sales are expected to decrease by 3.7 percent Y-o-Y (down 10.1 percent Q-o-Q) to Rs. 3,421.2 crore, according to Edelweiss.
Inthis articlepublished earlier, we discussed that both the markets, equity and debt, look stretched on valuations. At that point of time, the yield on the 10-year government security was approx 6.5% and the overnight interest rate, represented by the RBI repo rate, was 6.25%. The spread was only 25 basis points between overnight and 10-years. This was an anomaly as per the theory....More>>>